Evidence
How to improve sperm motility
Evidence on sperm motility: collection conditions, causes, and why a higher percentage is not a pregnancy result.
- Published
- Modified
- Clinician review
- Not yet
Short answer
A low motility result should first be checked against how the sample was produced and how quickly it was examined. Treatable causes belong to a clinician. Some trials report higher motility with carnitine or CoQ10. That is a semen-parameter finding. It is not evidence that pregnancy or live birth will follow, and SemenBoost does not recommend a dose.
Key takeaways
- Cold, delay and an incomplete sample can imitate poor motility.
- Progressive motility is the usual clinical concern.
- Carnitine and CoQ10 have parameter data of limited strength.
- NICE’s smoking statement is an association, with uncertain impact on fertility.
Rule out an artefact
Motility is the measurement most damaged by a wait. If the sample was produced at home, sat in a car, or was examined long after an hour, ask whether the laboratory wants a repeat on site. That repeat is a better “improvement plan” than a supplement started the same day.
What studies have reported
L-carnitine has been studied particularly for motility, often combined with acetyl-L-carnitine, over a few months. CoQ10 trials have also reported motility changes. The studies are small relative to the claims made in shops, doses differ, and pregnancy was often not the primary result. Details and the uncertainty are on the L-carnitine and CoQ10 pages.
The Cochrane antioxidant review is the right context for products sold as motility boosters. Live-birth evidence was very low certainty and not significant once high-risk-of-bias trials were removed.
Habits
Smoking is associated with reduced semen quality, which can include motility. NICE says the impact on male fertility is uncertain and still supports stopping for general health. Heavy alcohol intake is detrimental to semen quality in NICE’s wording. Heat exposure is a plausible, less firmly guided factor and is discussed separately so it is not oversold.
Evidence
Limited evidenceMotility can change with sample handling and with some studied ingredients. The evidence that those ingredient changes cause more pregnancies is limited to insufficient.
Semen parameters
Selected trials report improvements in progressive or total motility. They are not consistent enough, or large enough, to rate as moderate for routine use.
Pregnancy and live birth
Motility trials rarely show a reliable live-birth benefit for a named ingredient. Pooled antioxidant evidence is very low certainty.
A change in a semen measurement is not the same finding as a pregnancy or a live birth.
Related
Sources
- Fertility problems: assessment and treatment (NG257) — NICE, 2026
- Antioxidants for male subfertility — Cochrane, 2022
- WHO laboratory manual for the examination and processing of human semen, 6th edition — World Health Organization, 2021
How this page was prepared
Drafted with automated research assistance and checked against the cited primary sources. A named clinician has not reviewed this page. Medical review is pending. Changes to reference values are not published automatically.